企業プロフィール

PainReform 株価・ニュース・カタリスト

ティッカー:
PRFX
取引所:
NASDAQ
セクター:
Biopharma
所在地:
Israel and listed in the U

株価パフォーマンス

0.97 USD (-5.81%)

終値

最終更新: 2026年8月17日

1.75M USD

時価総額

株価変動の要因

As of Aug 17, 2026, PRFX closed down 5.81% at $0.9702. No new same-company headline was identified in the current news window.

企業概要

事業概要

PainReform is a specialty pharmaceutical company focused on pain management and formulation technology. Its story is built around improving local analgesia through delivery science rather than broad drug discovery.

所在地とセクター分類

PainReform is headquartered in Israel and listed in the U.S. market. It sits in specialty pharma and pain management.

ビジネスモデルの特徴

The company depends on clinical progress, formulation validation, and commercialization strategy. Investors typically watch data, market access, and capital runway.

バイオ業界での位置付け

PainReform occupies a niche pain-formulation position within healthcare. The stock is driven by whether its delivery platform can matter in a crowded pain market.

今後のカタリスト

  • PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction. The company still needs stronger adoption.

最近のニュース

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。